Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Innocan Pharma Corp
(CSE:
INNO
)
0.2500
+0.0100 (+4.17%)
Official Closing Price
Updated: 12:51 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Other Filings
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Form 8-K/A
Source:
SEC/Edgar
December 05, 2013
Form 8-K
Source:
SEC/Edgar
October 14, 2013
Form 8-K
Source:
SEC/Edgar
October 03, 2013
Form 8-K
Source:
SEC/Edgar
August 27, 2013
Form SC 13D/A
Source:
SEC/Edgar
July 23, 2013
Form 8-K
Source:
SEC/Edgar
July 18, 2013
Form 8-K
Source:
SEC/Edgar
July 14, 2013
Form 8-K
Source:
SEC/Edgar
July 02, 2013
Form 8-K
Source:
SEC/Edgar
July 02, 2013
Form 8-K
Source:
SEC/Edgar
April 14, 2013
Form 8-K
Source:
SEC/Edgar
April 11, 2013
Form DEF 14A
Source:
SEC/Edgar
March 10, 2013
Form 8-K
Source:
SEC/Edgar
February 20, 2013
Form 8-K
Source:
SEC/Edgar
February 18, 2013
Form 8-K
Source:
SEC/Edgar
February 05, 2013
Form 8-K
Source:
SEC/Edgar
January 21, 2013
Form 8-K
Source:
SEC/Edgar
January 14, 2013
Form 8-K
Source:
SEC/Edgar
December 20, 2012
Form 8-K
Source:
SEC/Edgar
December 10, 2012
Form 8-K
Source:
SEC/Edgar
November 19, 2012
Form 8-K
Source:
SEC/Edgar
October 14, 2012
Form DEF 14A
Source:
SEC/Edgar
October 08, 2012
Form 8-K
Source:
SEC/Edgar
July 15, 2012
Form 8-K
Source:
SEC/Edgar
April 11, 2012
Form 8-K
Source:
SEC/Edgar
April 02, 2012
Form 8-K
Source:
SEC/Edgar
March 22, 2012
Form 8-K
Source:
SEC/Edgar
March 04, 2012
Form 8-K
Source:
SEC/Edgar
February 27, 2012
Form S-8
Source:
SEC/Edgar
February 27, 2012
Form 8-K
Source:
SEC/Edgar
February 16, 2012
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.